Industry: Healthcare
Published Date: June-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 191
Report ID: PMRREP34572
1. Executive Summary
1.1.Global AI in Oncology Market Snapshot, 2024 and 2031
1.2.Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3.Key Market Trends
1.4.Future Market Projections
1.5.Premium Market Insights
1.6.Industry Developments and Key Market Events
1.7.PMR Analysis and Recommendations
2. Market Overview
2.1.Market Scope and Definition
2.2.Market Dynamics
2.2.1.Drivers
2.2.2.Restraints
2.2.3.Opportunity
2.2.4.Key Trends
2.3.Macro-Economic Factors
2.3.1.Global Sectorial Outlook
2.3.2.Global GDP Growth Outlook
2.3.3.Global Healthcare Spending Outlook
2.4.COVID-19 Impact Analysis
2.5.Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1.Product Adoption Analysis
3.2.Technology Assessment
3.3.Regulatory Landscape
3.4.Supply Chain Analysis
3.5.Key Deals and Mergers
3.6.PESTLE Analysis
3.7.Porter's Five Force Analysis
4. Price Analysis, 2023A
4.1.Key Highlights
4.2.Key Factors Impacting Indication Prices
4.3.Pricing Analysis, By Component
4.4.Regional Prices and Indication Preferences
5. Global AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
5.1.Key Highlights
5.1.1.Market Size (US$ Mn) and Y-o-Y Growth
5.1.2.Absolute $ Opportunity
5.2.Market Size (US$ Mn) Analysis and Forecast
5.2.1.Historical Market Size (US$ Mn) Analysis, 2018-2022
5.2.2.Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
5.3.Global AI in Oncology Market Outlook: Component
5.3.1.Introduction / Key Findings
5.3.2.Historical Market Size (US$ Mn) Analysis, By Component, 2018 - 2022
5.3.3.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
5.3.3.1.Software Solutions
5.3.3.2.Hardware
5.3.3.3.Services
5.4.Market Attractiveness Analysis: Component
5.5.Global AI in Oncology Market Outlook: Indication
5.5.1.Introduction / Key Findings
5.5.2.Historical Market Size (US$ Mn) Analysis, By Indication, 2018 - 2022
5.5.3.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
5.5.3.1.Breast Cancer
5.5.3.2.Lung Cancer
5.5.3.3.Prostate Cancer
5.5.3.4.Colorectal Cancer
5.5.3.5.Brain Tumour
5.5.3.6.Others
5.6.Market Attractiveness Analysis: Indication
5.7.Global AI in Oncology Market Outlook: Treatment
5.7.1.Introduction / Key Findings
5.7.2.Historical Market Size (US$ Mn) Analysis, By Treatment, 2018 - 2022
5.7.3.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
5.7.3.1.Chemotherapy
5.7.3.2.Immunotherapy
5.7.3.3.Radiotherapy
5.7.3.4.Others
5.8.Market Attractiveness Analysis: Treatment
5.9.Global AI in Oncology Market Outlook: End User
5.9.1.Introduction / Key Findings
5.9.2.Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
5.9.3.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
5.9.3.1.Hospitals
5.9.3.2.Biopharmaceutical Companies
5.9.3.3.Academic and Research Centers
5.9.3.4.Others
5.10.Market Attractiveness Analysis: End User
6. Global AI in Oncology Market Outlook: Region
6.1.Key Highlights
6.2.Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
6.3.Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
6.3.1.North America
6.3.2.Europe
6.3.3.East Asia
6.3.4.South Asia and Oceania
6.3.5.Latin America
6.3.6.Middle East & Africa
6.4.Market Attractiveness Analysis: Region
7. North America AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1.Key Highlights
7.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
7.2.1.By Country
7.2.2.By Component
7.2.3.By Indication
7.2.4.By Treatment
7.2.5.By End User
7.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1.U.S.
7.3.2.Canada
7.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
7.4.1.Software Solutions
7.4.2.Hardware
7.4.3.Services
7.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
7.5.1.Breast Cancer
7.5.2.Lung Cancer
7.5.3.Prostate Cancer
7.5.4.Colorectal Cancer
7.5.5.Brain Tumour
7.5.6.Others
7.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
7.6.1.Chemotherapy
7.6.2.Immunotherapy
7.6.3.Radiotherapy
7.6.4.Others
7.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
7.7.1.Hospitals
7.7.2.Biopharmaceutical Companies
7.7.3.Academic and Research Centers
7.7.4.Others
7.8.Market Attractiveness Analysis
8. Europe AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1.Key Highlights
8.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
8.2.1.By Country
8.2.2.By Component
8.2.3.By Indication
8.2.4.By Treatment
8.2.5.By End User
8.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1.Germany
8.3.2.France
8.3.3.U.K.
8.3.4.Italy
8.3.5.Spain
8.3.6.Russia
8.3.7.Türkiye
8.3.8.Rest of Europe
8.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
8.4.1.Software Solutions
8.4.2.Hardware
8.4.3.Services
8.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
8.5.1.Breast Cancer
8.5.2.Lung Cancer
8.5.3.Prostate Cancer
8.5.4.Colorectal Cancer
8.5.5.Brain Tumour
8.5.6.Others
8.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
8.6.1.Chemotherapy
8.6.2.Immunotherapy
8.6.3.Radiotherapy
8.6.4.Others
8.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
8.7.1.Hospitals
8.7.2.Biopharmaceutical Companies
8.7.3.Academic and Research Centers
8.7.4.Others
8.8.Market Attractiveness Analysis
9. East Asia AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1.Key Highlights
9.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
9.2.1.By Country
9.2.2.By Component
9.2.3.By Indication
9.2.4.By Treatment
9.2.5.By End User
9.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1.China
9.3.2.Japan
9.3.3.South Korea
9.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
9.4.1.Software Solutions
9.4.2.Hardware
9.4.3.Services
9.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
9.5.1.Breast Cancer
9.5.2.Lung Cancer
9.5.3.Prostate Cancer
9.5.4.Colorectal Cancer
9.5.5.Brain Tumour
9.5.6.Others
9.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
9.6.1.Chemotherapy
9.6.2.Immunotherapy
9.6.3.Radiotherapy
9.6.4.Others
9.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
9.7.1.Hospitals
9.7.2.Biopharmaceutical Companies
9.7.3.Academic and Research Centers
9.7.4.Others
9.8.Market Attractiveness Analysis
10. South Asia & Oceania AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1.Key Highlights
10.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
10.2.1.By Country
10.2.2.By Component
10.2.3.By Indication
10.2.4.By Treatment
10.2.5.By End User
10.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1.India
10.3.2.Southeast Asia
10.3.3.ANZ
10.3.4.Rest of South Asia & Oceania
10.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
10.4.1.Software Solutions
10.4.2.Hardware
10.4.3.Services
10.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
10.5.1.Breast Cancer
10.5.2.Lung Cancer
10.5.3.Prostate Cancer
10.5.4.Colorectal Cancer
10.5.5.Brain Tumour
10.5.6.Others
10.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
10.6.1.Chemotherapy
10.6.2.Immunotherapy
10.6.3.Radiotherapy
10.6.4.Others
10.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
10.7.1.Hospitals
10.7.2.Biopharmaceutical Companies
10.7.3.Academic and Research Centers
10.7.4.Others
10.8.Market Attractiveness Analysis
11. Latin America AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1.Key Highlights
11.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
11.2.1.By Country
11.2.2.By Component
11.2.3.By Indication
11.2.4.By Treatment
11.2.5.By End User
11.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1.Brazil
11.3.2.Mexico
11.3.3.Rest of Latin America
11.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
11.4.1.Software Solutions
11.4.2.Hardware
11.4.3.Services
11.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
11.5.1.Breast Cancer
11.5.2.Lung Cancer
11.5.3.Prostate Cancer
11.5.4.Colorectal Cancer
11.5.5.Brain Tumour
11.5.6.Others
11.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
11.6.1.Chemotherapy
11.6.2.Immunotherapy
11.6.3.Radiotherapy
11.6.4.Others
11.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
11.7.1.Hospitals
11.7.2.Biopharmaceutical Companies
11.7.3.Academic and Research Centers
11.7.4.Others
11.8.Market Attractiveness Analysis
12. Middle East & Africa AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
12.1.Key Highlights
12.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
12.2.1.By Country
12.2.2.By Component
12.2.3.By Indication
12.2.4.By Treatment
12.2.5.By End User
12.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
12.3.1.GCC Countries
12.3.2.Egypt
12.3.3.South Africa
12.3.4.Northern Africa
12.3.5.Rest of Middle East & Africa
12.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031
12.4.1.Software Solutions
12.4.2.Hardware
12.4.3.Services
12.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
12.5.1.Breast Cancer
12.5.2.Lung Cancer
12.5.3.Prostate Cancer
12.5.4.Colorectal Cancer
12.5.5.Brain Tumour
12.5.6.Others
12.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031
12.6.1.Chemotherapy
12.6.2.Immunotherapy
12.6.3.Radiotherapy
12.6.4.Others
12.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
12.7.1.Hospitals
12.7.2.Biopharmaceutical Companies
12.7.3.Academic and Research Centers
12.7.4.Others
12.8.Market Attractiveness Analysis
13. Competition Landscape
13.1.Market Share Analysis, 2023
13.2.Market Structure
13.2.1.Competition Intensity Mapping By Market
13.2.2.Competition Dashboard
13.3.Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1.Azra AI
13.3.1.1.Overview
13.3.1.2.Segments and Products
13.3.1.3.Key Financials
13.3.1.4.Market Developments
13.3.1.5.Market Strategy
13.3.2.IBM
13.3.2.1 Overview
13.3.2.2.Segments and Products
13.3.2.3.Key Financials
13.3.2.4.Market Developments
13.3.2.5.Market Strategy
13.3.3.Siemens Healthcare GmbH
13.3.3.1.Overview
13.3.3.2.Segments and Products
13.3.3.3.Key Financials
13.3.3.4.Market Developments
13.3.3.5.Market Strategy
13.3.4.Intel Corporation
13.3.4.1.Overview
13.3.4.2.Segments and Products
13.3.4.3.Key Financials
13.3.4.4.Market Developments
13.3.4.5.Market Strategy
13.3.5.GE Healthcare
13.3.5.1.Overview
13.3.5.2.Segments and Products
13.3.5.3.Key Financials
13.3.5.4.Market Developments
13.3.5.5.Market Strategy
13.3.6.NVIDIA Corporation
13.3.6.1.Overview
13.3.6.2.Segments and Products
13.3.6.3.Key Financials
13.3.6.4.Market Developments
13.3.6.5.Market Strategy
13.3.7.Digital Diagnostics Inc.
13.3.7.1.Overview
13.3.7.2.Segments and Products
13.3.7.3.Key Financials
13.3.7.4.Market Developments
13.3.7.5.Market Strategy
13.3.8.ConcertAI
13.3.8.1.Overview
13.3.8.2.Segments and Products
13.3.8.3.Key Financials
13.3.8.4.Market Developments
13.3.8.5.Market Strategy
13.3.9.Median Technologies
13.3.9.1.Overview
13.3.9.2.Segments and Products
13.3.9.3.Key Financials
13.3.9.4.Market Developments
13.3.9.5.Market Strategy
13.3.10.PathAI
13.3.10.1.Overview
13.3.10.2.Segments and Products
13.3.10.3.Key Financials
13.3.10.4.Market Developments
13.3.10.5.Market Strategy
13.3.11.Berg (BPGbio Inc.)
13.3.11.1.Overview
13.3.11.2.Segments and Products
13.3.11.3.Key Financials
13.3.11.4.Market Developments
13.3.11.5.Market Strategy
13.3.12.CancerCenter.AI
13.3.12.1.Overview
13.3.12.2.Segments and Products
13.3.12.3.Key Financials
13.3.12.4.Market Developments
13.3.12.5.Market Strategy
13.3.13.iCAD
13.3.13.1.Overview
13.3.13.2.Segments and Products
13.3.13.3.Key Financials
13.3.13.4.Market Developments
13.3.13.5.Market Strategy
13.3.14.JLK Inspection
13.3.14.1.Overview
13.3.14.2.Segments and Products
13.3.14.3.Key Financials
13.3.14.4.Market Developments
13.3.14.5.Market Strategy
13.3.15.Roche Diagnostics
13.3.15.1.Overview
13.3.15.2.Segments and Products
13.3.15.3.Key Financials
13.3.15.4.Market Developments
13.3.15.5.Market Strategy
13.3.16.Zebra Medical Vision
13.3.16.1.Overview
13.3.16.2.Segments and Products
13.3.16.3.Key Financials
13.3.16.4.Market Developments
13.3.16.5.Market Strategy
13.3.17.Illumina Inc.
13.3.17.1.Overview
13.3.17.2.Segments and Products
13.3.17.3.Key Financials
13.3.17.4.Market Developments
13.3.17.5.Market Strategy
13.3.18.Envisionit DeepAI Ltd
13.3.18.1.Overview
13.3.18.2.Segments and Products
13.3.18.3.Key Financials
13.3.18.4.Market Developments
13.3.18.5.Market Strategy
14. Appendix
14.1.Research Methodology
14.2.Research Assumptions
14.3.Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
